RADOBIO Scientific Co., Ltd. announced that it will receive CNY 12,000,000 in an equity round of funding on March 19, 2024. The transaction will include participation from new investor, Shanghai Titan Scientific Co., Ltd. for CNY 8,000,000 and Shanghai Titan Heyuan I Venture Capital Investment Partnership Enterprise (Limited Partnership) (?STHVC?) for CNY 4,000,000. Post closing the transaction, the registered capital of the company will increase from CNY 1,000,000 to CNY 1,428,571.43.

The round is raised a post-money valuation of CNY 28,000,000. The transaction has been approved by the investor Shanghai Titan Scientific Co., Ltd 4th directorate during its 7th meeting held. The investors will acquire 50% stake and 10% stake respectively including M&A.